PMID- 21566538 OWN - NLM STAT- MEDLINE DCOM- 20120312 LR - 20211020 IS - 1524-4040 (Electronic) IS - 0148-396X (Print) IS - 0148-396X (Linking) VI - 69 IP - 6 DP - 2011 Dec TI - An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. PG - 1281-90 LID - 10.1227/NEU.0b013e3182237346 [doi] AB - BACKGROUND: Recent interest has demonstrated the nucleus accumbens (NAcc) as a potential target for the treatment of depression with deep brain stimulation (DBS). OBJECTIVE: To demonstrate that DBS of the NAcc is an effective treatment modality for depression and that chemical and structural changes associated with these behavioral changes are markers of neuroplasticity. METHODS: A deep brain stimulator was placed in the NAcc of male Wistar-Kyoto rats. Groups were divided into sham (no stimulation), intermittent (3 h/d for 2 weeks), or continuous (constant stimulation for 2 weeks). Exploratory and anxietylike behaviors were evaluated with the open-field test before and after stimulation. Tissue samples of the prefrontal cortex (PFC) were processed with Western blot analysis of markers of noradrenergic activity that included the noradrenergic synthesizing enzyme tyrosine hydroxylase. Analysis of tissue levels for catecholamines was achieved with high-performance liquid chromatography. Morphological properties of cortical pyramidal neurons were assessed with Golgi-Cox staining. RESULTS: Subjects undergoing intermittent and continuous stimulation of the NAcc exhibited an increase in exploratory behavior and reduced anxietylike behaviors. Tyrosine hydroxylase expression levels were decreased in the PFC after intermittent and continuous DBS, and dopamine and norepinephrine levels were decreased after continuous stimulation. Golgi-Cox staining indicated that DBS increased the length of apical and basilar dendrites in pyramidal neurons of the PFC. CONCLUSION: Deep brain stimulation induces behavioral improvement in and neurochemical and morphological alterations of the PFC that demonstrate changes within the circuitry of the brain different from the target area of stimulation. This observed dendritic plasticity may underlie the therapeutic efficacy of this treatment. FAU - Falowski, Steven M AU - Falowski SM AD - Department of Neurosurgery, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. sfalowski@gmail.com FAU - Sharan, Ashwini AU - Sharan A FAU - Reyes, Beverly A S AU - Reyes BA FAU - Sikkema, Carl AU - Sikkema C FAU - Szot, Patricia AU - Szot P FAU - Van Bockstaele, Elisabeth J AU - Van Bockstaele EJ LA - eng GR - R01 DA009082/DA/NIDA NIH HHS/United States PT - Journal Article PL - United States TA - Neurosurgery JT - Neurosurgery JID - 7802914 RN - 0 (Catecholamine Plasma Membrane Transport Proteins) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) SB - IM MH - Animals MH - Catecholamine Plasma Membrane Transport Proteins/metabolism MH - Chromatography, High Pressure Liquid MH - Deep Brain Stimulation/*methods MH - Depression/pathology/physiopathology/psychology/*therapy MH - Disease Models, Animal MH - Exploratory Behavior/*physiology MH - Gene Expression Regulation/physiology MH - Male MH - Neuronal Plasticity/*physiology MH - Nucleus Accumbens/*physiology MH - Prefrontal Cortex/metabolism/pathology MH - Pyramidal Cells/physiopathology/ultrastructure MH - Random Allocation MH - Rats MH - Rats, Inbred WKY MH - Silver Staining MH - Tyrosine 3-Monooxygenase/metabolism PMC - PMC4707959 MID - NIHMS748529 COIS- Disclosure The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article. EDAT- 2011/05/14 06:00 MHDA- 2012/03/13 06:00 PMCR- 2016/01/11 CRDT- 2011/05/14 06:00 PHST- 2011/05/14 06:00 [entrez] PHST- 2011/05/14 06:00 [pubmed] PHST- 2012/03/13 06:00 [medline] PHST- 2016/01/11 00:00 [pmc-release] AID - 10.1227/NEU.0b013e3182237346 [doi] PST - ppublish SO - Neurosurgery. 2011 Dec;69(6):1281-90. doi: 10.1227/NEU.0b013e3182237346.